Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

One Or Multiple Investigational Sites, Japan Clinical Trials

A listing of One Or Multiple Investigational Sites, Japan clinical trials actively recruiting patients volunteers.

RESULTS

Found (11) clinical trials

Acute Treatment Trial in Adult Subjects With Migraines  

Phase

Are you Living with PCOS? Consider a clinical research study at Medical Research Center of Memphis. We’re testing the safety and effectiveness of an investigational drug for women diagnosed with Polycystic Ovary Syndrome (PCOS).  

Phase

The purpose of this study is to estimate nicotine uptake and assess subjective effects during ad lib use sessions of an electronic nicotine delivery system with multiple flavors and nicotine concentrations as compared to an e-cigarette, conventional cigarettes, and nicotine gum in adult smokers ages 21 to 65.  

Phase

A research study is evaluating the effects of an investigational topical medication combined with light therapy for the potential treatment of Cutaneous T-Cell Lymphoma.

Phase

People with ovarian cancer are asked to participate in a research study being conducted by Montefiore Medical Center.  

Phase

Researchers at the University of Kentucky are studying how certain molecules may play an important role in your health and adaptation to exercise. All research procedures will take place in the UK Chandler Hospital and the College of Health Sciences.  PARTICIPANTS WILL BE COMPENSATED FOR THEIR TIME  

Phase

Chronic lymphocytic leukemia (CLL) and/or small lymphocytic lymphoma (SLL) are tumors of B cells that often affect elderly patients. While the cause of CLL is still unclear, studies have indicated critical factors required for the tumor cells. First, CLL cells grow and survive because they receive signals through the B-cell ...

Phase

Severe aplastic anemia (SAA) and myelodysplastic syndrome (MDS) are life-threatening bone marrow disorders. For SAA patients, long term survival can be achieved with immunosuppressive treatment. However, of those patients treated with immunosuppressive therapy, one quarter to one third will not respond, and about 50 percent of responders will relapse. Allogeneic ...

Phase

Most acquired aplastic anemia ensues from immune-mediated destruction of hematopoietic stem and progenitor cells Immunosuppression is the definitive treatment of patients with acquired aplastic anemia who are not candidates for immediate hematopoietic stem cell transplantation. Horse ATG combined with the calcineurin inhibitor, cyclosporine (CsA), remains standard as first-line immunosuppressive therapy ...

Phase

Polymerization of deoxy-sickle-hemoglobin (deoxy-HbS), the root cause of sickle cell disease (SCD) is influenced by a few factors, a key factor is 2,3-diphosphoglycerate (2,3-DPG) concentration in the red blood cells. 2,3-DPG is an allosteric effector on hemoglobin oxygen binding with a greater binding affinity to deoxygenated hemoglobin than to oxygenated ...

Phase